Table 3

Visual outcomes following IAM for retinoblastoma: functional, vascular (FFA) and structural results

FunctionVascularStructure
Patient
(age)
VA
ERG/VEP
pre-IAM
VA
ERG/VEP
post 1st IAM
VA
ERG/VEP
post-2nd IAM
Post-3rd
IAM
Post-4th
IAM
Post-5th
IAM
VA last visitSectoral choroid changeDiffusechoroid changeLocal RDDiffuse RD
1
(15 m)
LE
BEO:6/30cc 0.5m
20/100
LE fix preference
ERG/VEP:ND

LE fix preference
ERG/VEP:ND
BEO: 6/38cc1m
20/125
LE fix pref
ERG/VEP:ND
NDNDNDLE: no FFNoNoNoYes
2
(24 m)
LE
BEO: 6/24cc1m
20/80
LE fix preference
ERG/VEP:ND
BEO: 6/24cc1m
20/80
ERG/VEP:ND
BEO: 6/60
6 m Kays
20/200
ERG/VEP:ND
NDNDNDLE: 1.5/60
Kays singles
20/240
NoYesNoNo
3
(11 m)
RE
RE: 6/30cc1m
20/100
ERG Normal
PoVEP:6.25′
RE:6/24cc1m
20/80
ERG: stable
PoVEP: sl ↓
RE:6/24cc1m
20/80
ERG: stable
PoVEP: stable
NDNDNDRE:6/12 Kays
20/40
MLN RE
Yes (fovea spared)NoNoNo
4
(24 m)
RE
RE: 6/19cc1m
ERG: R<L
PrVEP BEO good
Flash VEP RE=LE
RE:6/9Kays
20/30
ERG/VEP: ND
RE:6/5Kays
20/16
ERG/VEP: ND
NDNDNDRE:6/9 SG
20/30
NoNoNoNo
5
(11 m)
RE
BEO:6/9cc1m
20/30
(equal objection to occlusion)
ERG: R<L
PoVEP 25′R<L
BEO: 6/15cc1m
20/50
(LE fix pref)
ERG RE rod ↓
PoVEP sl ↓
RE:6/60cc 50 cm 20/200
ERG/VEP:ND
NDNDNDRE: FFYes (entire temporal retina)NoNoNo
6
(20 m)
LE
BEO:6/15cc1m
20/50
ERG: R=L N
fVEP flash only
BEO:6/12cc1m
20/40
ERG: LE ↓
fVEP stable
BEO:6/12cc1m
20/40
ERG/VEP: ND
NDNDNDLE: 6/9 Kays
20/30
MLN RE
NoNoNoNo
7
(11 m)
LE
LE: 3.8cpd Keeler
20/166
ERG: N
PrVEP: N 6.25′
LE: 5.3cpd Keeler
20/100
ERG: ↓
PrVEP: ↓

ND

ND

ND

ND
LE: 6/9.5
CC 1m
20/30
MLN LE
Yes (fovea spared)NoNoNo
8
(40 m)
LE
LE:6/5Kays
20/16
ERG: mixed L<R
PrVEP LE<RE 6.25′
LE:6/5 Kays
20/16
ERG:cone delay
PrVEP: stable
LE:6/5 Kays
20/16
ERG:stable
PrVEP: stable
LE:
6/6
Kays
20/20
ND
LE:
1/60
Kays
ND
LE:
1/60 SG
ND
LE:
1/60 SG
20/1300
NoYes (nasal retina spared)NoNo

9
(82 m)
LE
LE:6/6 Snellen
20/20
PERG: L<R
ERG: N LE & RE
PrVEP: L<R 6.25′
EOG: N L<R
LE:6/5 Snellen
20/16
PERG L ↑
ERG: stable
PrVEP: stable
EOG: stable
LE:6/4Snellen
20/12
PERG: stable
ERG: stable
PrVEP: stable
EOG: stable
LE:
5/60
20/20
ND
NDNDLE: 6/76
Snellen
20/252

Yes (fovea)
NoNoNo
10
(9 m)
RE
BEO:3.8cpd
Keeler
20/166
(objects RE occlusion)
ERG/VEP:ND
RE FF
(objects RE occlusion)
ERG/VEP:ND
BEO: 6/15cc1m
20/50
ERG mixed N
PrVEP:
BEO100′ abn
NDNDNDBEO: 6/15
20/50
CC1 m RE: FF
MLN LE
NoNoNoNo

11
(11 m)
RE
BEO:6/12CC1m
20/40
ERG RE N
ERG LE delay
PrVEP BEO 6.25′
BEO:6/15CC1 m 20/50
ERG RE stable
ERG LE ↓ ↓ ↓
PrVEP BEO stable
BEO:6/15CC
1 m 20/50
ERG/VEP:ND
BEO:
6/19 CC 1m
20/63
ND

ND

ND
BEO:
6/12
CC 1m20/40
MLN
Yes (fovea spared)NoNoNo
12
(73 m)
LE
LE:6/9 Snellen20/30
ERG L abn
PrVEP 6.25′
LE:6/6-2 Snellen20/20
ERG L ↓
PrVEP stable

LE:6/6-2 20/20
Snellen
ND
LE:
6/6-20/20
ND

ND

ND
LE:
6/7.6-1
Snellen
20/25
NoNoNoNo
  • Blue: VA normal for age.

  • Green: Snellen equivalent in feet.

  • Shaded cells indicate deterioration in function (pale grey electrophysiological) and structure.

  • abn, abnormal; BEO, both eyes open; CC, Cardiff Cards; ERG, electroretinograms; FFA, fundus fluorescein angiography; fVEP, flash VEP; IAM, intra-arterial melphalan; LE, left eye; MLN, manifest latent nystagmus; N, normal; ND, not done; PERG, pattern ERG; PoVEP, pattern onset VEP; PrVEP, pattern reversal VEP; RD, retinal detachment; RE, right eye; VA, visual acuity; VEP, visual evoked potentials.